Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase IIb trial of methylnaltrexone begins for narcotic-induced constipation

Feb. 25, 2002

Recent patent covers Boehringer Ingelheim compounds useful for the treatment of HCV infection

Feb. 21, 2002

sNDA submitted for Prevacid in pediatric patients

Feb. 21, 2002

Aciphex indications expanded

Feb. 19, 2002

Abbott/Ligand jointly identify selective glucocorticoid modulators

Feb. 18, 2002

COLAL-PRED enters late-stage trials for ulcerative colitis

Feb. 18, 2002

Positive preclinical and clinical results for NCX-1015 in IBD and arthritis

Feb. 18, 2002

New antibiotic with selective activity against H. pylori

Feb. 18, 2002

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Feb. 15, 2002

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...